DRKS00024180
Recruiting
Not Applicable
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C83.3
- Sponsor
- niversitätsklinikum Freiburg
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Consenting patients with histologically confirmed non\-Hodgkin lymphoma.
Exclusion Criteria
- •Minors, nursing mothers, pregnant women, patients not capable of giving consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
Not yet recruiting
Not Applicable
Circulating tumor DNA as biomarker for perihilar cholangiocarcinomaPerihilar cholangiocarcinoma/ Perihilair cholangiocarcinoomKlatskin-tumorBiomarkerCirculating tumor DNA /Circulerend tumor DNA (ctDNA)NL-OMON27478AMC20
Completed
Not Applicable
Circulating tumor DNA as a biomarker in perihilar cholangiocarcinoma: a feasibility studybiliary tract cancerperihilar cholangiocarcinoma10019815NL-OMON43203Academisch Medisch Centrum20
Completed
Not Applicable
ctDNA as a Biomarker for Treatment Response in HNSCCCarcinoma, Squamous Cell of Head and NeckNCT03540563The Netherlands Cancer Institute70
Completed
Not Applicable
Prospective Evaluation of Circulating Tumour DNA (ctDNA) as Molecular Monitoring Tool and Prognostic Biomarker in Resectable Pancreatic AdenocarcinomasC25Malignant neoplasm of pancreasDRKS00010992niversitätsklinikum Freiburg25